Influence of treatment schedule and viral challenge dose on the in vivo influenza virus-inhibitory effects of the orally administered neuraminidase inhibitor GS 4104

Antiviral Chemistry and Chemotherapy

Volumn 10, Issue 4, 1999, Pages 187-193

  Sidwell, Robert W ^a   Bailey, Kevin W ^a   Bemis, Paul A ^a   Wong, Min Hui ^a   Eisenberg, Eugene J ^b   Huffman, John H ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

GS 4104; Influenza virus; Mouse model; Neuraminidase inhibitor

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; INFLUENZA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0032812577     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029901000403     Document Type: Article

References (15)

1. Burnet FM (1948) Mucins and mucoids in relation to influenza virus action. Australian Journal of Experimental Biology and Medical Sciences 26:381-387.
2. Eisenberg EJ, Bidgood A & Cundy KC (1997) Penetration of GS4071, a novel neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104. Antimicrobial Agents and Chemotherapy 41:1949-1952.
3. Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG & Stevens RC (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carhocyclic sialic acid analogues with potent anti-influenza activity. Journal of the American Chemical Society 119:681-690.
4. Klenk HD & Rott R (1988) The molecular biology of influenza virus pathogenicity. Advances in Virus Research 34:247-280.
5. Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, Merson J, Lew W, Williams M, Zhang L, Kim CU, Bischofberger N, Chen MS & Mendel DB (1998) Identification of GS4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS4071. Antimicrobial Agents and Chemotherapy 42:647-653.
6. Liu C, Eichelberger MC, Compans RW & Air GM (1995) Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. Journal of Virology 69:1099-1106.
7. Mendel D & Sidwell RW (1998) Influenza virus resistance to neuraminidase inhibitors. Drug Resistance Updates 1:184-189.
8. Mendel D, Tai CY, Escarpe PA, Li W, Sidwell RW, Huffman JH, Sweet C, Jakeman KJ, Merson J, Lacy SA, Lew W, Williams MA, Zhang L, Chen MS, Bischofberger N & Kim CU (1998) Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS4071 protects mice and ferrets against influenza infection. Antimicrobial Agents and Chemotherapy 42:640-646.
9. Palese P & Compans RW (1976) Inhibition of influenza virus replication in tissue culture by 2-deoxy-2, 3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. Journal of General Virology 33:159-163.
10. Palese P, Tobita K, Ueda M & Compans RW (1974) Characterization of temperature sensitive influenza virus mutants. Virology 61:397-410.
11. Sidwell RW (1986) Determination of antiviral activity. In Modern Analysis of Antibiotics, pp. 433-480. Edited by A Aszalos. New York: Marcel Dekker.
12. Sidwell RW, Huffman JH, Call EW, Alaghamandan H, Cook PD & Robins RK (1986) Effect of selenazofurin on influenza A and B virus infections of mice. Antiviral Research 6:343-353.
13. Sidwell RW, Huffman JH, Gilbert J, Moscon B, Pedersen G, Burger R & Warren RP (1992) Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrobial Agents and Chemotherapy 36:473:476.
14. Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T & Kim CU (1998) Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Research 37:107-120.
15. Tai CY, Escarpe PA, Sidwell RW, Williams MA, Lew W, Wu H, Kim CU & Mendel DB (1998) Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071. Antimicrobial Agents Chemotherapy 42:3234-3241.